Cabaletta Bio, Inc.
CABA
$1.59
-$0.03-1.85%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 33.11% | 42.50% | 43.28% | 64.88% | 66.75% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 49.69% | 56.58% | 67.61% | 68.84% | 64.34% |
| Operating Income | -49.69% | -56.58% | -67.61% | -68.84% | -64.34% |
| Income Before Tax | -60.35% | -64.91% | -71.21% | -66.71% | -56.60% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -60.35% | -64.91% | -71.21% | -66.71% | -56.60% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -60.35% | -64.91% | -71.21% | -66.71% | -56.60% |
| EBIT | -49.69% | -56.58% | -67.61% | -68.84% | -64.34% |
| EBITDA | -50.11% | -57.14% | -68.54% | -70.15% | -65.82% |
| EPS Basic | -42.44% | -48.12% | -41.44% | -25.38% | -9.79% |
| Normalized Basic EPS | -42.44% | -48.14% | -41.46% | -25.39% | -9.79% |
| EPS Diluted | -42.20% | -48.08% | -41.47% | -25.43% | -9.82% |
| Normalized Diluted EPS | -42.44% | -48.14% | -41.46% | -25.39% | -9.79% |
| Average Basic Shares Outstanding | 12.82% | 12.34% | 20.95% | 30.16% | 40.58% |
| Average Diluted Shares Outstanding | 12.82% | 12.34% | 20.95% | 30.16% | 40.58% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |